Positive/Negative Clinical intervention

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.

rxforlife2004

Membership Revoked
Removed
5+ Year Member
15+ Year Member
Advertisement - Members don't see this ad
I just went for a job interview last week and the pharm director asked me if i could explain in details about a positive/negative clinical intervention during hospital rotations...Boy, am i the only person here that hates these kinda questions? Or anyone knows how to handle such questions? Grr...i think i bombed it...
 
I'd say you need to do some reading on outcomes management of clinical pharmacy interventions.

Just because you can get a dose to achieve a particular vancomycin trough does not necessarily mean you've done the pt any good - especially when you've not looked at the peak & kept that where it should be.

Sorry about the interview - but, this will give you something to work on for the next one.
 
Vanco is a time dependent drug, thus, time above MIC is what you need to worry about, not peak concentrations. Target a level of about 4-5x that of the MIC of the bug and keep it at that level for at least 50% of the time and you should be good.
 
Advertisement - Members don't see this ad
Vanco is a time dependent drug, thus, time above MIC is what you need to worry about, not peak concentrations. Target a level of about 4-5x that of the MIC of the bug and keep it at that level for at least 50% of the time and you should be good.

Good job - but.....that was not the point.

The point was being able to discern a positive or negative clinical intervention. I just used vanco as an example of how it could be used either way.........
 
Well, usually I'm a pretty good BSer, but those questions do throw me sometimes. For that particular question, though, I think it boils down to whether your intervention ultimately helped the patient in the long-run. If you ended up, say, giving a patient ampho B to treat sepsis, but the patient died 2 days later from ARF, then that's a negative clinical intervention. But, if you treated another patient with clindamycin for a life-threatening peritoneal B. fragillis infection, and you cured the infection but temporarily gave the patient CDAD, that would be a positive clinical intervention. Hopefully that helps a bit. 😀